Key result
Ultrasound-assisted thrombolysis shows no benefit over standard catheter-directed thrombolysis for RV/LV ratio reduction.
Why the study?
Does ultrasound assisted thrombolysis improve efficacy and safety outcomes compared to standard catheter-directed thrombolysis in patients with submassive or massive pulmonary embolism?
Meta-Analysis (n=381)
Does ultrasound assisted thrombolysis improve efficacy and safety outcomes compared to standard catheter-directed thrombolysis in patients with submassive or massive pulmonary embolism?
Answers are grounded in this paper and cite their sources.
Ultrasound-assisted thrombolysis does not provide additional efficacy or safety benefits over standard catheter-directed thrombolysis for the treatment of submassive or massive pulmonary embolism.
Background The use of catheter-based thrombolysis in comparison to systemic thrombolytics has emerged as a potentially lifesaving therapy for patients with sub massive or massive pulmonary embolism (PE). The addition of ultrasound waves to accelerate lytic dispersion in ultrasound assisted thrombolysis (USAT) has been proposed to improve outcomes as compared to standard catheter-directed thrombolysis (SCDT). These two modalities have been compared in small studies, but larger population data on the outcomes of these therapies is still lacking. Purpose To assess the efficacy and safety of USAT versus SCDT in patients with submassive or massive pulmonary embolism. Methods A review of electronic databases (PubMed, Scopus, Embase, and Cochrane) was performed using keywords USAT, SCDT and PE and studies were included if efficacy and safety outcomes were compared between the two types of therapies. Efficacy outcomes that were evaluated included the reduction in right ventricle/left ventricle ratio (RV/LV ratio), pulmonary artery systolic pressure (PASP) and Miller score. Safety outcomes that were evaluated included major bleeding, mortality and length of ICU stay. Standardized mean differences (SMD) and 95% confidence intervals (CI) were calculated for continuous variables. Risk ratio (RR) and 95% CI were reported for dichotomous variables using the random effects model in comprehensive meta-analysis and RevMan 5.4.1 softwares. Results Six studies with a total of 381 patients (USAT n=204; SCDT n=177) were included. No statistical difference in efficacy outcomes of USAT over SCDT was noted in the degree of RV/LV ratio reduction (SMD: −0.507; CI: −1.386–0.373; p>0.05; I2=92%), PASP reduction (SMD: 0.037; CI: −0.404–0.478; p>0.05; I2=59%), or Miller score reduction (SMD: 0.303; CI: −0.481– 1.087; p>0.05; I2=82%). Safety outcomes were also not statistically different with similar rates of major bleeding (RR: 1.44; CI: 0.54–3.85; p>0.05; I2=4%), mortality (RR: 1.46; CI: 0.35–6.05; p>0.05; I2=0%) and length of ICU stay (SMD: −0.01; CI: −0.29–0.27; p>0.05; I2=31%) in both treatment groups. Conclusion Our data suggest that despite the technological advancement of USAT, there is no additional benefit over SCDT in terms of efficacy and safety. Further studies are warranted for both procedures investigating financial and clinical outcomes in real world practice.
No takes yet. Share an insight, caveat, or question.
Kaur et al. (2022) conducted a meta-analysis in submassive or massive pulmonary embolism (n=381). Ultrasound assisted thrombolysis (USAT) vs. Standard catheter-directed thrombolysis (SCDT) was evaluated on reduction in right ventricle/left ventricle ratio (RV/LV ratio) (SMD -0.507, 95% CI -1.386-0.373, p=>0.05). Ultrasound assisted thrombolysis provided no additional benefit over standard catheter-directed thrombolysis for RV/LV ratio reduction.
Synapse has enriched 10 related papers. Consider them for comparative context: